Related references
Note: Only part of the references are listed.Pharmacokinetic comparison of two bazedoxifene acetate 20 mg tablet formulations in healthy Korean male volunteers
Ji-Sun Yeun et al.
TRANSLATIONAL AND CLINICAL PHARMACOLOGY (2020)
Assessment of the Effects of Age and Renal Function on Pharmacokinetics of Bazedoxifene in Postmenopausal Women
William McKeand et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
Pharmacokinetics, Dose Proportionality, and Bioavailability of Bazedoxifene in Healthy Postmenopausal Women
William McKeand
CLINICAL THERAPEUTICS (2017)
Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry
Naveen Kadian et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Postmenopausal osteoporosis
Richard Eastell et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
The use of calcium and vitamin D in the management of osteoporosis
John Sunyecz
Therapeutics and Clinical Risk Management (2016)
Bioequivalence of Generic Drugs: A Simple Explanation for a US Food and Drug Administration Requirement
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2015)
A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture
Santiago Palacios et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2015)
Comparison of the Pharmacokinetics, Safety, and Tolerability of Vitamin D3 in DP-R206 (150-mg Ibandronate/24,000-IU Vitamin D3 Tablet) and as Monotherapy (24,000 IU) in Healthy Male Korean Adults
Ji-Young Jeon et al.
CLINICAL THERAPEUTICS (2014)
The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
Nicole C. Wright et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Prevention and treatment of postmenopausal osteoporosis
Sri Harsha Tella et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Osteoporosis Prevention, Screening, and Treatment: A Review
Juliana M. Kling et al.
JOURNAL OF WOMENS HEALTH (2014)
Clinician's Guide to Prevention and Treatment of Osteoporosis
F. Cosman et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis
Davide Gatti et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Bioavailability of Vitamin D2 and D3 in Healthy Volunteers, a Randomized Placebo-Controlled Trial
Ulrike Lehmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial
Gloria Bachmann et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2011)
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
Hisaya Kawate et al.
CLINICAL INTERVENTIONS IN AGING (2011)
Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis
Santiago Palacios
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
Patrick Garnero et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
Barbara M. Davit et al.
ANNALS OF PHARMACOTHERAPY (2009)
Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis
Annie W. C. Kung et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis
Catherine MacLean et al.
ANNALS OF INTERNAL MEDICINE (2008)
Fixed-dose combinations improve medication compliance: A meta-analysis
Sripal Bangalore et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Compliance with osteoporosis medications
DH Solomon et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Bazedoxifene acetate: A selective estrogen receptor modulator with improved selectivity
BS Komm et al.
ENDOCRINOLOGY (2005)
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women
S Ronkin et al.
OBSTETRICS AND GYNECOLOGY (2005)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
